世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
人工呼吸器市場：移動性（集中治療、携帯）、タイプ、モード（容積、圧力、複合）、インターフェース（侵襲、非侵襲）、エンドユーザー（病院、クリニック、在宅医療、ACC、救急医療サービス）、地域別 - 2026年までの世界市場予測Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Clinic, Home Care, ACC, Emergency Medical Services), Region - Global Forecast to 2026 人工呼吸器市場は、2021年の14億米ドルから2026年には19億米ドルに達すると予測され、予測期間中のCAGRは7.6%となります。人工呼吸器、呼吸器、レスピレーターは、呼吸を補助する機械です。主に病院で、慢性閉塞... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー人工呼吸器市場は、2021年の14億米ドルから2026年には19億米ドルに達すると予測され、予測期間中のCAGRは7.6%となります。人工呼吸器、呼吸器、レスピレーターは、呼吸を補助する機械です。主に病院で、慢性閉塞性肺疾患（COPD）、睡眠時無呼吸症候群、急性肺損傷、低酸素血症の治療に使用されています。長年にわたり、高度な携帯型人工呼吸器の開発や人工呼吸器に使用されるセンサー技術の向上などの技術的進歩により、人工呼吸器市場は大きく発展してきました。早産児の増加、老年人口の急増、呼吸器疾患の有病率の上昇、ICUのベッド数の増加、COVID-19患者の増加などが、予測期間中の人工呼吸器市場の成長を促進すると予想されます。在宅医療の出現は、人工呼吸器市場に新たな道を開いています。在宅医療環境における利便性と快適性、そしてコストメリットは、人工呼吸器の在宅医療市場の成長を促す他の主要な要因となっています。"集中治療分野が人工呼吸器市場で最大のシェアを占めると予想" 2020年の世界の人工呼吸器市場において、集中治療分野は最大のシェアを占めています。集中治療用人工呼吸器セグメントの大きなシェアは、人工呼吸器を備えた集中治療用ベッドの数が増加していることに起因しています。また、先進国におけるCOVID-19や再入院によるICU入院の増加、適切な診療報酬も、ICU用人工呼吸器セグメントの大きなシェアの要因となっています。 "成人/小児用人工呼吸器セグメントが人工呼吸器市場で最大のシェアを占める見込み" 2020年の人工呼吸器市場において、成人/小児用人工呼吸器セグメントが最大のシェアを占めている。成人/小児用人工呼吸器セグメントの大きなシェアは、COVID-19に苦しむ成人人口の多さ、COPD＆喘息などの慢性疾患の発生率の増加、喫煙者の増加、老年人口の増加などに起因しているものと思われます。 "人工呼吸器市場において、侵襲的換気装置が最大のシェアを占める見込み" 2020年の人工呼吸器市場では、侵襲的換気分野が最大のシェアを占めています。侵襲的換気市場の成長は、COVID-19患者における重症度の増加や、呼吸器疾患、神経疾患、睡眠障害の有病率の上昇に起因すると考えられる。 "複合型換気装置分野が人工呼吸器市場で最大シェアを占める見込み" 2020年の人工呼吸器市場において、複合モード型人工呼吸器が最大のシェアを占めています。このセグメントの大きなシェアは、従来の圧力モード換気や容積モード換気に対する優位性に起因しているものと思われる。複合モード換気は、両方の換気モードを提供できるため、換気装置市場において望ましい製品となっている。 "病院・クリニック部門が人工呼吸器市場で最高シェアを獲得" 病院・診療所向け人工呼吸器市場は、高価な機器を購入できる病院の経済力、および人工呼吸器を操作する訓練を受けた専門家の存在により、予測期間中に圧倒的なシェアを占めると考えられます。また、コロナウイルス疾患の発生率が急速に高まっていることも、市場成長の原動力となっています。COVID-19の大流行により、医療資源が圧迫されただけでなく、入院患者数も増加しています。 "予測期間中は北米が人工呼吸器市場を支配する" 予測期間中、人工呼吸器市場は北米が圧倒的なシェアを占めています。老人人口の増加、喫煙者の増加、呼吸器疾患の高い有病率、COVID-19患者数の増加、高度に発達した医療制度、高い医療費、米国の主要な市場参加者が、北米の人工呼吸器市場を牽引する主要因となっています。 本レポートで参照した人工呼吸器市場の主要参加者の内訳は以下のとおりです。 - 企業タイプ別Tier 1-34%、Tier 2-38%、Tier 3-28%。 - 役職別Cレベル-26％、ディレクターレベル-35％、その他-39 - 地域別北米-17％、欧州-39％、アジア太平洋-28％、中南米-8％、中東・アフリカ-8％。 人工呼吸器市場の有力企業には、Koninklijke Philips N.V.（オランダ）、ResMed（米国）、Medtronic（アイルランド）、Fisher & Paykel Healthcare Limited（ニュージーランド）、Drägerwerk AG & CO.KGAA（ドイツ）、日本光電工業株式会社（日本）、Getinge AB（スウェーデン）、旭化成株式会社（日本）、エア・リキード（フランス）、Vyaire Medical, Inc.(米国）、GEヘルスケア（米国）、ハミルトンメディカル（スイス）、Smiths Group plc（英国）、Allied Healthcare Products, Inc.(米国）、Shenzhen Mindray Bio-Medical Electronics Co.Ltd（中国）、aXcent Medical GmbH（ドイツ）、メトラン株式会社（日本）、MAGNAMED（ブラジル）、Avasarala Technologies Ltd（インド）、Airon Corporation（フロリダ）、TRITON Electronic Systems Ltd. (米国)、Allied Healthcare Products (米国)。(ロシア)、Bio-Med Devices, Inc.(アメリカ)、Hill-Rom Holdings, Inc.(米国）、HEYER Medical AG（ドイツ）、Leistung Engineering Pvt.Ltd.（ドイツ）。(アルゼンチン)。 調査対象 本レポートでは、各種人工呼吸器の市場やその採用パターンを分析しています。また、同市場の主要企業の企業プロファイル、製品・サービス内容、最近の動向など、詳細な競合分析も行っています。 本レポートを購入する理由 このレポートは、既存企業だけでなく、新規参入者/小規模企業が市場の脈拍を測定するために豊かになり、その結果、より大きなシェアを獲得するのに役立つだろう。レポートを購入する企業は、彼らの市場の存在を強化するための以下の5つの戦略の1つまたは任意の組み合わせを使用することができます。 本レポートでは、以下のポイントについて考察しています。 - 市場の浸透。世界の人工呼吸器市場のトッププレーヤーが提供する製品ポートフォリオに関する包括的な情報 - 製品開発/イノベーション。人工呼吸器の世界市場における今後の動向、研究開発活動、製品・サービスの上市に関する詳細な洞察 - 市場開発。製品、アプリケーション、エンドユーザー、地域ごとに、有利な新興地域に関する包括的な情報 - 市場の多様化。世界の人工呼吸器市場における新製品、成長地域、最近の開発に関する徹底的な情報。 - 競争力の評価。世界の人工呼吸器市場における主要企業の市場シェア、成長戦略、収益分析、製品・サービスに関する詳細な評価。
SummaryThe ventilators market is projected to reach USD 1.9 billion in 2026 from USD 1.4 billion in 2021, at a CAGR of 7.6% during the forecast period. A ventilator, breathing machine, or respirator is a machine that assists with breathing. It is mainly used in hospitals to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung injury, and hypoxemia. Over the years, the ventilators market has evolved significantly due to technological advancements, such as developing advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, rising number of ICU beds, and rising number of COVID-19 patients are expected to drive growth in the ventilators market during the forecast period. The emergence of home healthcare has opened new avenues for the ventilators market. Convenience and comfort in the home care environment, coupled with cost advantages, are the other major factors driving growth in the home healthcare market for ventilators. Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 VENTILATORS MARKET SEGMENTATION 34
FIGURE 2 VENTILATORS MARKET, BY REGION 34
1.4 YEARS CONSIDERED 35
1.5 CURRENCY 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.6 LIMITATIONS 36
1.7 STAKEHOLDERS 36
1.8 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 4 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS:
SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VENTILATORS MARKET) 42
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 45
FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: VENTILATORS MARKET (2020) 46
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR THE VENTILATORS MARKET (2021–2026) 47
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 13 TOP-DOWN APPROACH 48
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 50
FIGURE 14 DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 51
2.6 LIMITATIONS 51
2.6.1 METHODOLOGY-RELATED LIMITATIONS 52
2.7 RISK ASSESSMENT 52
TABLE 2 RISK ASSESSMENT: VENTILATORS MARKET 52
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VENTILATORS MARKET 52
3 EXECUTIVE SUMMARY 54
FIGURE 15 VENTILATORS MARKET, BY MOBILITY, 2021 VS. 2026 (USD MILLION) 54
FIGURE 16 VENTILATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 18 VENTILATORS MARKET, BY MODE, 2021 VS. 2026 (USD MILLION) 56
FIGURE 19 VENTILATORS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 56
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF THE VENTILATORS MARKET 57
4 PREMIUM INSIGHTS 58
4.1 VENTILATORS MARKET OVERVIEW 58
FIGURE 21 COVID-19 PANDEMIC AND GROWTH IN THE PREVALENCE OF CHRONIC RESPIRATORY DISEASES ARE DRIVING THE GROWTH OF THE VENTILATORS MARKET 58
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY & COUNTRY (2020) 59
FIGURE 22 INTENSIVE CARE VENTILATORS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC VENTILATORS MARKET IN 2020 59
4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 23 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 60
4.4 VENTILATORS MARKET: REGIONAL MIX 60
FIGURE 24 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2026 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 25 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 High prevalence of respiratory diseases 62
5.2.1.1.1 High prevalence of COPD and asthma 62
5.2.1.1.2 High prevalence of tobacco smoking 62
TABLE 3 PREVALENCE AND DEATHS CAUSED DUE TO SMOKING 63
5.2.1.2 Rapid growth in the global geriatric population 63
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 63
5.2.1.3 Government initiatives toward increasing the availability of ventilators amidst the COVID-19 pandemic 63
5.2.1.4 Increasing number of patients transferred to intensive care units 64
5.2.1.5 Outbreak of the COVID-19 pandemic 64
5.2.1.6 Growing preference for home-based oxygen therapy 64
5.2.2 RESTRAINTS 64
5.2.2.1 Dearth of skilled medical workers 64
5.2.2.2 Over purchase of ventilators in hospitals 65
5.2.2.3 Reimbursement concerns 65
5.2.3 OPPORTUNITIES 65
5.2.3.1 Development of non-invasive and microprocessor-controlled portable ventilators 65
5.2.3.2 Growth in healthcare spending 66
TABLE 4 TOTAL HEALTH EXPENDITURE PER CAPITA IN PURCHASING
POWER PARITY (USD) 66
5.2.3.3 Cost advantages of home care services 66
5.2.3.4 Growth opportunities in emerging countries 66
5.2.4 CHALLENGES 67
5.2.4.1 Low awareness and a large population of undiagnosed & undertreated patients 67
5.2.4.2 Harmful effects of certain devices on neonates 67
6 INDUSTRY INSIGHTS 68
6.1 TECHNOLOGY ANALYSIS 68
6.1.1 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET 68
6.1.1.1 Introduction 68
6.1.1.2 The future of healthcare—Big Data and artificial intelligence 68
6.1.1.3 Knowledge-based systems for ventilation management 69
FIGURE 27 AI INTEGRATION INTO VENTILATORS 69
6.1.1.4 COVID-19 to drive the demand for artificial intelligence in ventilators 69
6.1.2 SENSOR TECHNOLOGIES IN VENTILATORS 70
6.1.2.1 Introduction 70
6.1.2.2 Flow sensors 70
6.1.2.3 Oxygen sensors 71
6.1.2.4 Pressure sensors 71
6.1.3 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL 72
6.1.3.1 E-Nose technology 72
6.1.3.2 MEMS technology 72
6.1.3.3 Electrochemical technology 72
6.1.3.4 Paramagnetic technology 73
6.1.3.5 Wireless gas sensor technology 73
6.2 INDUSTRY TRENDS 73
TABLE 5 MARKET CONSOLIDATION AND THE RISING DEMAND FOR PORTABLE VENTILATORS ARE THE MAJOR TRENDS IN THE MARKET 73
6.2.1 RISING DEMAND FOR ENHANCED PORTABLE AND COMPACT VENTILATORS 74
6.2.2 CONSOLIDATION OF THE MARKET 74
FIGURE 28 RECENT ACQUISITIONS IN THE MARKET 74
6.2.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 75
6.2.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATION 75
6.2.5 NON-MEDICAL COMPANIES ENTERING THE MARKET TO CATER TO THE INCREASING DEMAND FOR VENTILATORS 75
6.3 FACTOR ANALYSIS 76
6.3.1 POPULATION SCENARIO 76
FIGURE 29 TOTAL POPULATION, BY COUNTRY/REGION 76
FIGURE 30 URBAN POPULATION, BY COUNTRY/REGION 76
FIGURE 31 GERIATRIC POPULATION (AGED ABOVE 65 YEARS) 77
6.3.2 HEALTHCARE EXPENDITURE 78
FIGURE 32 THE US ACCOUNTED FOR THE HIGHEST HEALTHCARE
EXPENDITURE (% OF GDP) 78
6.3.3 TARGET POPULATION 79
FIGURE 33 COVID-19 POPULATION: TOTAL POPULATION VS. RECOVERED POPULATION 79
6.4 PRICING ANALYSIS 79
TABLE 6 AVERAGE SELLING PRICE OF VENTILATORS OFFERED BY TOP PLAYERS 79
6.5 VALUE CHAIN ANALYSIS 80
FIGURE 34 VALUE CHAIN: VENTILATORS MARKET 81
6.6 ECOSYSTEM MAPPING 81
FIGURE 35 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 82
6.7 SUPPLY CHAIN ANALYSIS 82
6.8 PORTER’S FIVE FORCES ANALYSIS 84
TABLE 7 PORTER’S FIVE FORCES ANALYSIS 84
6.8.1 THREAT OF NEW ENTRANTS 84
6.8.2 THREAT OF SUBSTITUTES 85
6.8.3 BARGAINING POWER OF SUPPLIERS 85
6.8.4 BARGAINING POWER OF BUYERS 85
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 85
6.9 REGULATORY ANALYSIS 86
6.9.1 NORTH AMERICA 86
6.9.1.1 US 86
6.9.1.2 Canada 86
6.9.2 EUROPE 86
6.9.3 ASIA PACIFIC 86
6.9.3.1 Japan 86
6.9.3.2 China 87
6.9.3.3 India 87
6.10 PATENT ANALYSIS 87
6.10.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 87
FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN THE VENTILATORS MARKET, 2015–2020 88
6.10.2 TOP APPLICANTS (COMPANIES) OF VENTILATOR PATENTS 88
FIGURE 38 TOP COMPANIES THAT APPLIED FOR VENTILATOR PATENTS, 2015–2020 88
6.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE VENTILATORS MARKET 89
FIGURE 39 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR VENTILATOR PATENTS, 2015–2020 89
6.11 TRADE ANALYSIS 89
TABLE 8 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY 89
6.12 CASE STUDY ANALYSIS 90
TABLE 9 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES 90
TABLE 10 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS 91
6.13 IMPACT OF COVID-19 ON THE VENTILATORS MARKET 91
7 VENTILATORS MARKET, BY MOBILITY 92
7.1 INTRODUCTION 93
TABLE 11 VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 93
7.2 INTENSIVE CARE VENTILATORS 93
TABLE 12 MAJOR PRODUCTS: ICU VENTILATORS 94
TABLE 13 INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 14 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 15 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 96
7.2.1 HIGH-END ICU VENTILATORS 96
7.2.1.1 Improving healthcare infrastructure and rising healthcare expenditure in developing countries to drive market growth 96
TABLE 16 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 17 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 98
7.2.2 MID-END ICU VENTILATORS 98
7.2.2.1 Mid-end ICU ventilators are in high demand owing to the
COVID-19 pandemic 98
TABLE 18 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 19 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 100
7.2.3 BASIC ICU VENTILATORS 100
7.2.3.1 Basic ICU ventilators are equipped with minimal features as compared to high-end and mid-end ICU ventilators 100
TABLE 20 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 21 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 102
7.3 PORTABLE/TRANSPORTABLE VENTILATORS 102
7.3.1 LOW WEIGHT AND ROBUST NATURE HAVE INCREASED THE DEMAND FOR PORTABLE/TRANSPORTABLE VENTILATORS 102
TABLE 22 MAJOR PRODUCTS: PORTABLE/TRANSPORTABLE VENTILATORS 103
TABLE 23 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 24 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 105
8 VENTILATORS MARKET, BY TYPE 106
8.1 INTRODUCTION 107
TABLE 25 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
8.2 ADULT/PEDIATRIC VENTILATORS 107
8.2.1 INCREASING NUMBER OF COVID-19 CASES AMONG ADULTS DRIVING THE DEMAND FOR ADULT VENTILATORS 107
TABLE 26 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
8.3 NEONATAL/INFANT VENTILATORS 108
8.3.1 NEW TECHNOLOGIES AND INNOVATIONS IN THE FIELD OF NEONATAL VENTILATORS TO DRIVE MARKET GROWTH 108
TABLE 27 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
9 VENTILATORS MARKET, BY INTERFACE 110
9.1 INTRODUCTION 111
TABLE 28 VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 111
9.2 INVASIVE VENTILATION 111
9.2.1 INCREASING CASES OF COVID-19 AND RISING PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH 111
TABLE 29 INVASIVE VENTILATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
9.3 NON-INVASIVE VENTILATION 112
9.3.1 INCREASING ADOPTION OF NON-INVASIVE VENTILATION AMONG END USERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 112
TABLE 30 NON-INVASIVE VENTILATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
10 VENTILATORS MARKET, BY END USER 114
10.1 INTRODUCTION 115
TABLE 31 VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 115
10.2 HOSPITALS & CLINICS 115
10.2.1 GROWING PATIENT VOLUMES DUE TO COVID-19 TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 115
TABLE 32 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2019–2026 (USD MILLION) 116
10.3 AMBULATORY CARE CENTERS 116
10.3.1 GROWING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH IN THIS
END-USER SEGMENT 116
TABLE 33 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 117
10.4 EMERGENCY MEDICAL SERVICES 118
10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 34 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 118
10.5 HOME CARE SETTINGS 119
10.5.1 HOME CARE VENTILATORS ARE CONVENIENT AND CAN BE USED IN THE COMFORT OF THE PATIENT’S HOME—KEY FACTORS DRIVING MARKET GROWTH 119
TABLE 35 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2019–2026 (USD MILLION) 120
11 VENTILATORS MARKET, BY REGION 121
11.1 INTRODUCTION 122
FIGURE 40 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 122
TABLE 36 VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
11.2 NORTH AMERICA 123
FIGURE 41 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 124
TABLE 37 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 38 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 125
TABLE 39 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 40 NORTH AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 41 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 126
TABLE 42 NORTH AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 126
TABLE 43 NORTH AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 126
11.2.1 US 127
11.2.1.1 The US dominated the North American ventilators market in 2020 127
TABLE 44 US: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 127
TABLE 45 US: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 128
TABLE 46 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 47 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 48 US: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 128
TABLE 49 US: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 129
TABLE 50 US: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 129
11.2.2 CANADA 129
11.2.2.1 Increasing incidence of COPD is driving the adoption of ventilators in Canada 129
TABLE 51 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 130
TABLE 52 CANADA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 130
TABLE 53 CANADA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 131
TABLE 54 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 55 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 56 CANADA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 132
TABLE 57 CANADA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 132
TABLE 58 CANADA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 132
11.3 EUROPE 133
FIGURE 42 EUROPE: VENTILATORS MARKET SNAPSHOT 134
TABLE 59 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 60 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 135
TABLE 61 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 62 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 63 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 136
TABLE 64 EUROPE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 136
TABLE 65 EUROPE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 137
11.3.1 GERMANY 137
11.3.1.1 Germany dominated the ventilators market in Europe in 2019 137
TABLE 66 GERMANY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 137
TABLE 67 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 138
TABLE 68 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 69 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 70 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 138
TABLE 71 GERMANY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 139
TABLE 72 GERMANY: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 139
11.3.2 FRANCE 139
11.3.2.1 The highly advanced and well-established healthcare system in France driving market growth 139
TABLE 73 FRANCE: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 140
TABLE 74 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 140
TABLE 75 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 76 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 77 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 141
TABLE 78 FRANCE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 141
TABLE 79 FRANCE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 142
11.3.3 UK 142
11.3.3.1 Increasing healthcare expenditure is driving the growth of the ventilators market in the country 142
TABLE 80 UK: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 143
TABLE 81 UK: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 143
TABLE 82 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 83 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 84 UK: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 144
TABLE 85 UK: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 144
TABLE 86 UK: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 145
11.3.4 ITALY 145
11.3.4.1 Presence of a well-developed healthcare system in the country and rapid growth in the aging population to drive market growth 145
TABLE 87 ITALY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 146
TABLE 88 ITALY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 146
TABLE 89 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 90 ITALY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 91 ITALY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 147
TABLE 92 ITALY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 147
TABLE 93 ITALY: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
11.3.5 SPAIN 148
11.3.5.1 Increasing geriatric population to drive market growth in Spain 148
TABLE 94 SPAIN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 148
TABLE 95 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 149
TABLE 96 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 97 SPAIN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 98 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 150
TABLE 99 SPAIN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 150
TABLE 100 SPAIN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 150
11.3.6 NETHERLANDS 151
11.3.6.1 Increasing patient population to support market growth in the Netherlands 151
TABLE 101 NETHERLANDS: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 151
TABLE 102 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 151
TABLE 103 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 104 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 105 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 152
TABLE 106 NETHERLANDS: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 153
TABLE 107 NETHERLANDS: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 153
11.3.7 REST OF EUROPE 153
TABLE 108 ROE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 154
TABLE 109 ROE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 110 ROE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 111 ROE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 155
TABLE 112 ROE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 155
TABLE 113 ROE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 155
11.4 ASIA PACIFIC 156
FIGURE 43 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 157
TABLE 114 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 115 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 158
TABLE 116 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 117 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 118 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 159
TABLE 119 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 159
TABLE 120 ASIA PACIFIC: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 160
11.4.1 JAPAN 160
11.4.1.1 Japan’s established healthcare system to support market growth during the forecast period 160
TABLE 121 JAPAN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 161
TABLE 122 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 161
TABLE 123 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 124 JAPAN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 125 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 162
TABLE 126 JAPAN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 162
TABLE 127 JAPAN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 163
11.4.2 CHINA 163
11.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for ventilators in China 163
TABLE 128 CHINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 164
TABLE 129 CHINA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 164
TABLE 130 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 131 CHINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 132 CHINA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 165
TABLE 133 CHINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 165
TABLE 134 CHINA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 166
11.4.3 INDIA 166
11.4.3.1 Increasing COVID-19 patient volume to drive the ventilators market in India 166
TABLE 135 INDIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 167
TABLE 136 INDIA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 167
TABLE 137 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 138 INDIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 139 INDIA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 168
TABLE 140 INDIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 168
TABLE 141 INDIA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 169
11.4.4 AUSTRALIA 169
11.4.4.1 High prevalence of chronic diseases to drive the demand for ventilators in Australia during the forecast period 169
TABLE 142 AUSTRALIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 170
TABLE 143 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 170
TABLE 144 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 145 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 146 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 171
TABLE 147 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 171
TABLE 148 AUSTRALIA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 172
11.4.5 REST OF ASIA PACIFIC 172
TABLE 149 ROAPAC: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 172
TABLE 150 ROAPAC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 151 ROAPAC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 152 ROAPAC: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 173
TABLE 153 ROAPAC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 174
TABLE 154 ROAPAC: VENTILATORS MARKET, BY END USER,2019–2026 (USD MILLION) 174
11.5 LATIN AMERICA 174
TABLE 155 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 156 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 175
TABLE 157 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 158 LATIN AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 159 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 176
TABLE 160 LATIN AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 176
TABLE 161 LATIN AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 177
11.5.1 BRAZIL 177
11.5.1.1 Healthcare infrastructure improvement to support market growth in Brazil 177
TABLE 162 BRAZIL: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 178
TABLE 163 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 178
TABLE 164 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 165 BRAZIL: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 166 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 82019–2026 (USD MILLION) 179
TABLE 167 BRAZIL: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 179
TABLE 168 BRAZIL: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 180
11.5.2 MEXICO 180
11.5.2.1 Rising obesity rate to increase the incidence rate of respiratory diseases in Mexico 180
TABLE 169 MEXICO: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 181
TABLE 170 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 181
TABLE 171 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 172 MEXICO: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 173 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 182
TABLE 174 MEXICO: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 182
TABLE 175 MEXICO: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 183
11.5.3 ARGENTINA 183
11.5.3.1 Rising prevalence of respiratory diseases in Argentina to drive market growth 183
TABLE 176 ARGENTINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 183
TABLE 177 ARGENTINA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 184
TABLE 178 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 179 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 180 ARGENTINA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 185
TABLE 181 ARGENTINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 185
TABLE 182 ARGENTINA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 185
11.5.4 REST OF LATIN AMERICA 186
TABLE 183 ROLATAM: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 186
TABLE 184 ROLATAM: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 185 ROLATAM: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 186 ROLATAM: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 187
TABLE 187 ROLATAM: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 187
TABLE 188 ROLATAM: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 187
11.6 MIDDLE EAST & AFRICA 188
11.6.1 GROWING GERIATRIC POPULATION TO DRIVE GROWTH IN THE MIDDLE EAST & AFRICA 188
TABLE 189 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 188
TABLE 190 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 191 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 192 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 189
TABLE 193 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 190
TABLE 194 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 190
12 COMPETITIVE LANDSCAPE 191
12.1 INTRODUCTION 191
TABLE 195 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO JANUARY 2022) 191
12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 192
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET 192
12.3 MARKET SHARE ANALYSIS 192
FIGURE 45 VENTILATORS MARKET SHARE, BY KEY PLAYER, 2020 193
12.4 COMPETITIVE SCENARIO 194
12.4.1 PRODUCT LAUNCHES 194
TABLE 196 VENTILATORS MARKET: SERVICE LAUNCHES
(JANUARY 2018 TO JANUARY 2022) 194
12.4.2 DEALS 195
TABLE 197 VENTILATORS MARKET: DEALS (JANUARY 2018 TO JANUARY 2022) 195
12.4.3 OTHER DEVELOPMENTS 196
TABLE 198 VENTILATORS MARKET: OTHER DEVELOPMENTS
(JANUARY 2018 TO JANUARY 2022) 196
12.5 COMPETITIVE BENCHMARKING 197
12.5.1 FOOTPRINT OF KEY PLAYERS IN THE VENTILATORS MARKET 197
12.5.2 MOBILITY FOOTPRINT OF COMPANIES 198
12.5.3 TYPE FOOTPRINT OF COMPANIES 199
12.5.4 INTERFACE FOOTPRINT OF COMPANIES 200
12.5.5 MODE FOOTPRINT OF COMPANIES 201
12.5.6 END-USER FOOTPRINT OF COMPANIES 202
12.5.7 REGIONAL FOOTPRINT OF COMPANIES 203
FIGURE 46 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN VENTILATORS MARKET 204
12.6 VENTILATORS MARKET: R&D EXPENDITURE 205
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN THE VENTILATORS MARKET (2019 VS. 2020) 205
12.7 COMPANY EVALUATION MATRIX 205
12.7.1 STARS 206
12.7.2 EMERGING LEADERS 206
12.7.3 PERVASIVE PLAYERS 206
12.7.4 EMERGING COMPANIES 206
FIGURE 48 VENTILATORS MARKET: GLOBAL COMPANY EVALUATION MATRIX 207
12.8 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 207
12.8.1 PROGRESSIVE COMPANIES 207
12.8.2 STARTING BLOCKS 208
12.8.3 RESPONSIVE COMPANIES 208
12.8.4 DYNAMIC COMPANIES 208
FIGURE 49 VENTILATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS 208
13 COMPANY PROFILES 209
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS 209
13.1.1 KONINKLIJKE PHILIPS N.V. 209
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 209
FIGURE 50 COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V. (2020) 210
13.1.2 RESMED 213
TABLE 200 RESMED INC.: BUSINESS OVERVIEW 213
FIGURE 51 COMPANY SNAPSHOT: RESMED (2020) 214
13.1.3 MEDTRONIC 217
TABLE 201 MEDTRONIC: BUSINESS OVERVIEW 217
FIGURE 52 COMPANY SNAPSHOT: MEDTRONIC (2020) 218
13.1.4 VYAIRE MEDICAL, INC. 221
TABLE 202 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW 221
13.1.5 GETINGE AB 224
TABLE 203 GETINGE AB: BUSINESS OVERVIEW 224
FIGURE 53 COMPANY SNAPSHOT: GETINGE AB (2020) 225
13.1.6 DRÄGERWERK AG & CO. KGAA 228
TABLE 204 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 228
FIGURE 54 COMPANY SNAPSHOT: DRÄGERWERK AG & CO. KGAA (2020) 228
13.1.7 SMITHS GROUP PLC 231
TABLE 205 SMITHS GROUP PLC: BUSINESS OVERVIEW 231
FIGURE 55 COMPANY SNAPSHOT: SMITHS GROUP PLC (2020) 232
13.1.8 HAMILTON MEDICAL 234
TABLE 206 HAMILTON MEDICAL: BUSINESS OVERVIEW 234
13.1.9 GE HEALTHCARE 236
TABLE 207 GE HEALTHCARE: BUSINESS OVERVIEW 236
FIGURE 56 COMPANY SNAPSHOT: GE HEALTHCARE (2020) 237
13.1.10 FISHER & PAYKEL HEALTHCARE LIMITED 239
TABLE 208 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW 239
FIGURE 57 COMPANY SNAPSHOT: FISHER & PAYKEL HEALTHCARE LIMITED (2020) 240
13.2 OTHER PLAYERS 242
13.2.1 AIR LIQUIDE 242
TABLE 209 AIR LIQUIDE: BUSINESS OVERVIEW 242
FIGURE 58 COMPANY SNAPSHOT: AIR LIQUIDE (2020) 243
13.2.2 ASAHI KASEI CORPORATION 245
TABLE 210 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 245
FIGURE 59 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION (2020) 246
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC. 248
TABLE 211 ALLIED HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW 248
FIGURE 60 COMPANY SNAPSHOT: ALLIED HEALTH PRODUCTS, INC. (2020) 248
13.2.4 NIHON KOHDEN CORPORATION 250
TABLE 212 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 250
FIGURE 61 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION (2020) 251
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 253
13.2.6 AXCENT MEDICAL GMBH 253
13.2.7 METRAN CO., LTD. 254
13.2.8 MAGNAMED 254
13.2.9 LEISTUNG ENGINEERING PVT. LTD. 255
13.2.10 AVASARALA TECHNOLOGIES LIMITED 255
13.2.11 AIRON CORPORATION 256
13.2.12 TRITON ELECTRONIC SYSTEMS LTD. 256
13.2.13 HILL-ROM HOLDINGS, INC. 257
13.2.14 BIO-MED DEVICES, INC. 257
13.2.15 HEYER MEDICAL AG 258
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 259
14.1 DISCUSSION GUIDE 259
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
14.3 AVAILABLE CUSTOMIZATIONS 266
14.4 RELATED REPORTS 266
14.5 AUTHOR DETAILS 267
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（不動産）の最新刊レポート
MarketsandMarkets社のその他分野での最新刊レポート
本レポートと同じKEY WORD（mobility）の最新刊レポートよくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
